TCL Archive “Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers April 17, 1981
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983